Anteris Technologies Ltd (AVR)

Sydney
22.500
-0.750(-3.23%)
  • Volume:
    9,599
  • Bid/Ask:
    22.440/22.500
  • Day's Range:
    22.000 - 22.990

AVR Overview

Prev. Close
23.25
Day's Range
22-22.99
Revenue
9.26M
Open
22.99
52 wk Range
8-30.89
EPS
-3.29
Volume
9,599
Market Cap
312.75M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
16,632
P/E Ratio
-6.32
Beta
0.504
1-Year Change
172.73%
Shares Outstanding
13,900,216
Next Earnings Date
25 Oct 2022
What is your sentiment on Anteris Technologies Ltd?
or
Market is currently closed. Voting is open during market hours.

Anteris Technologies Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Anteris Technologies Ltd Analysis

Anteris Technologies Ltd Company Profile

Anteris Technologies Ltd Company Profile

Anteris Technologies Ltd is an Australia-based structural heart company engaged in developing technologies solutions that help healthcare professionals. The Company’s segments include Operations and Projects. The Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. The Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. It offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold that re-engineers xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellNeutral
Technical IndicatorsBuyStrong BuyStrong SellStrong SellStrong Buy
SummaryNeutralNeutralStrong SellStrong SellBuy